TW200744585A - Inhibitors of PAI-1 for treatment of muscular conditions - Google Patents
Inhibitors of PAI-1 for treatment of muscular conditionsInfo
- Publication number
- TW200744585A TW200744585A TW096106440A TW96106440A TW200744585A TW 200744585 A TW200744585 A TW 200744585A TW 096106440 A TW096106440 A TW 096106440A TW 96106440 A TW96106440 A TW 96106440A TW 200744585 A TW200744585 A TW 200744585A
- Authority
- TW
- Taiwan
- Prior art keywords
- muscle
- inhibitors
- pai
- treatment
- muscular conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77752106P | 2006-02-27 | 2006-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200744585A true TW200744585A (en) | 2007-12-16 |
Family
ID=38438022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW096106440A TW200744585A (en) | 2006-02-27 | 2007-02-26 | Inhibitors of PAI-1 for treatment of muscular conditions |
Country Status (20)
Country | Link |
---|---|
US (1) | US20070203220A1 (zh) |
EP (1) | EP2010171A2 (zh) |
JP (1) | JP2009528290A (zh) |
KR (1) | KR20080108407A (zh) |
CN (1) | CN101384256A (zh) |
AR (1) | AR059629A1 (zh) |
AU (1) | AU2007217363A1 (zh) |
BR (1) | BRPI0710964A2 (zh) |
CA (1) | CA2643731A1 (zh) |
CR (1) | CR10253A (zh) |
EC (1) | ECSP088699A (zh) |
GT (1) | GT200800167A (zh) |
IL (1) | IL192975A0 (zh) |
MX (1) | MX2008011015A (zh) |
NO (1) | NO20083438L (zh) |
PE (1) | PE20071017A1 (zh) |
RU (1) | RU2008128475A (zh) |
TW (1) | TW200744585A (zh) |
WO (1) | WO2007098278A2 (zh) |
ZA (1) | ZA200807357B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG176477A1 (en) * | 2006-08-07 | 2011-12-29 | Ironwood Pharmaceuticals Inc | Indole compounds |
GB0812192D0 (en) * | 2008-07-03 | 2008-08-13 | Lectus Therapeutics Ltd | Calcium ion channel modulators & uses thereof |
AR084433A1 (es) | 2010-12-22 | 2013-05-15 | Ironwood Pharmaceuticals Inc | Inhibidores de la faah y composiciones farmaceuticas que los contienen |
CN103724357B (zh) * | 2012-10-11 | 2016-06-08 | 中国药科大学 | 一种3,4-二氢吡喃并[3,2-b]吲哚-2-酮类化合物的合成方法 |
WO2017073060A1 (ja) * | 2015-10-29 | 2017-05-04 | 国立大学法人東北大学 | コラーゲン産生抑制剤 |
EP3429636A4 (en) * | 2016-03-17 | 2019-11-20 | Vanderbilt University | IMPROVEMENT OF PLASMINACTIVITY FOR PREVENTING SOFT TISSUE CALIBRATION |
CN115697385A (zh) * | 2020-05-11 | 2023-02-03 | 泰伦基国际有限公司 | 一种治疗脊髓性肌萎缩症的方法和药物 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW591020B (en) * | 2001-06-20 | 2004-06-11 | Wyeth Corp | 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
TWI240723B (en) * | 2001-06-20 | 2005-10-01 | Wyeth Corp | Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
US7291639B2 (en) * | 2001-06-20 | 2007-11-06 | Wyeth | Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
ATE367812T1 (de) * | 2001-06-20 | 2007-08-15 | Wyeth Corp | Substituierte indolsäurederivate als inhibitoren von plasminogen-aktivator-inhibitor-1 (pai-1) |
TWI224101B (en) * | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
ES2268480T3 (es) * | 2002-12-10 | 2007-03-16 | Wyeth | Derivados del acido 3-alquilo- y 3-arilalquilo-1h-indol-1-il-acetico sustituidos como inhibidores del inhibidor del activador del plasminogeno-1 (pai-1). |
WO2004052855A2 (en) * | 2002-12-10 | 2004-06-24 | Wyeth | Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
CN1726191A (zh) * | 2002-12-10 | 2006-01-25 | 惠氏公司 | 用作纤溶酶原激活物抑制剂-1(pai-1)的抑制剂的取代的吲哚氧代-乙酰氨基乙酸衍生物 |
UA80453C2 (en) * | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
JP2006510673A (ja) * | 2002-12-10 | 2006-03-30 | ワイス | プラスミノゲンアクティベータインヒビター1(pai−1)のインヒビターとしての、アリール、アリールオキシ、および、アルキルオキシ置換1h−インドール−3−イルグリオキシル酸誘導体 |
US7582773B2 (en) * | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
US7351726B2 (en) * | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
US7446201B2 (en) * | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
US7420083B2 (en) * | 2003-09-25 | 2008-09-02 | Wyeth | Substituted aryloximes |
US7265148B2 (en) * | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
US7342039B2 (en) * | 2003-09-25 | 2008-03-11 | Wyeth | Substituted indole oximes |
US7411083B2 (en) * | 2003-09-25 | 2008-08-12 | Wyeth | Substituted acetic acid derivatives |
US7141592B2 (en) * | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
US20050215626A1 (en) * | 2003-09-25 | 2005-09-29 | Wyeth | Substituted benzofuran oximes |
US7268159B2 (en) * | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
US7332521B2 (en) * | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
US7442805B2 (en) * | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
US7534894B2 (en) * | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
US7163954B2 (en) * | 2003-09-25 | 2007-01-16 | Wyeth | Substituted naphthyl benzothiophene acids |
KR20070055563A (ko) * | 2004-08-23 | 2007-05-30 | 와이어쓰 | 혈전증 및 심혈관 질병의 치료에 유용한 플라스미노겐활성화제 억제제 타입-1(pai-1)의 조절제로서의옥사졸로-나프틸 산 |
RU2007106869A (ru) * | 2004-08-23 | 2008-09-27 | Вайет (Us) | Тиазол-нафтиловые кислоты как ингибиторы ингибитора активации плазминогена-1 |
WO2006023864A1 (en) * | 2004-08-23 | 2006-03-02 | Wyeth | Pyrrolo-naphthyl acids as pai-1 inhibitors |
BRPI0614340A2 (pt) * | 2005-08-17 | 2011-04-12 | Wyeth Corp | indóis substituìdos e métodos de seu uso |
-
2007
- 2007-02-26 RU RU2008128475/15A patent/RU2008128475A/ru not_active Application Discontinuation
- 2007-02-26 AU AU2007217363A patent/AU2007217363A1/en not_active Abandoned
- 2007-02-26 US US11/679,031 patent/US20070203220A1/en not_active Abandoned
- 2007-02-26 AR ARP070100784A patent/AR059629A1/es unknown
- 2007-02-26 CA CA002643731A patent/CA2643731A1/en not_active Abandoned
- 2007-02-26 TW TW096106440A patent/TW200744585A/zh unknown
- 2007-02-26 BR BRPI0710964-4A patent/BRPI0710964A2/pt not_active IP Right Cessation
- 2007-02-26 PE PE2007000203A patent/PE20071017A1/es not_active Application Discontinuation
- 2007-02-26 JP JP2008556476A patent/JP2009528290A/ja not_active Withdrawn
- 2007-02-26 MX MX2008011015A patent/MX2008011015A/es unknown
- 2007-02-26 WO PCT/US2007/005069 patent/WO2007098278A2/en active Application Filing
- 2007-02-26 EP EP07751803A patent/EP2010171A2/en not_active Withdrawn
- 2007-02-26 CN CNA2007800059111A patent/CN101384256A/zh active Pending
- 2007-02-26 KR KR1020087018533A patent/KR20080108407A/ko not_active Application Discontinuation
-
2008
- 2008-07-22 IL IL192975A patent/IL192975A0/en unknown
- 2008-08-05 NO NO20083438A patent/NO20083438L/no unknown
- 2008-08-25 GT GT200800167A patent/GT200800167A/es unknown
- 2008-08-26 ZA ZA200807357A patent/ZA200807357B/xx unknown
- 2008-08-26 EC EC2008008699A patent/ECSP088699A/es unknown
- 2008-08-27 CR CR10253A patent/CR10253A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX2008011015A (es) | 2008-11-14 |
KR20080108407A (ko) | 2008-12-15 |
EP2010171A2 (en) | 2009-01-07 |
AU2007217363A1 (en) | 2007-08-30 |
CA2643731A1 (en) | 2007-08-30 |
PE20071017A1 (es) | 2007-11-12 |
ZA200807357B (en) | 2009-08-26 |
ECSP088699A (es) | 2008-09-29 |
IL192975A0 (en) | 2009-08-03 |
CR10253A (es) | 2008-11-18 |
WO2007098278A2 (en) | 2007-08-30 |
WO2007098278A3 (en) | 2008-03-20 |
GT200800167A (es) | 2009-01-15 |
NO20083438L (no) | 2008-10-31 |
US20070203220A1 (en) | 2007-08-30 |
AR059629A1 (es) | 2008-04-16 |
CN101384256A (zh) | 2009-03-11 |
BRPI0710964A2 (pt) | 2012-02-28 |
JP2009528290A (ja) | 2009-08-06 |
RU2008128475A (ru) | 2010-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009009761A (es) | Composiciones y estuches para tratamiento de la influenza. | |
WO2007092622A3 (en) | Compositions and methods for treating bone | |
MX2009007075A (es) | Metodos de uso para analogos de ciclopamina. | |
IL233634A0 (en) | Methods, compositions and kits for treating medical conditions | |
WO2008127290A3 (en) | Alginate and alginate lyase compositions and methods of use | |
WO2008013589A3 (en) | Treatment of ras-expressing tumors | |
UA95644C2 (ru) | Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний | |
WO2008124660A3 (en) | Methods and compositions for the treatment of cancer | |
GB2466912A (en) | Compositions and methods for treating lysosomal disorders | |
TW200744585A (en) | Inhibitors of PAI-1 for treatment of muscular conditions | |
WO2008022024A3 (en) | Imidazole amines as inhibitors of beta-secretase | |
MX2012004780A (es) | Inhibidores de akt. | |
UA100190C2 (en) | Akt and p70 s6 kinase inhibitors | |
MX2009005300A (es) | Combinacion de un inhibidor de acido desoxirribonucleico polimerasa-alfa y un inhibidor de una cinasa de punto de verificacion para trastornos proliferativos. | |
TW200716088A (en) | Formulations and methods for treating amyloidosis | |
MX2011010918A (es) | Metodo para el tratamiento de trastornos asociados con la actividad de la cinasa de proteina ck2. | |
WO2009009034A3 (en) | Methods and compositions useful in the treatment of mucositis | |
WO2007100777A3 (en) | Methods for the treatment of adhd and related disorders | |
WO2010021934A3 (en) | Azaindole inhibitors of iap | |
WO2009129497A3 (en) | Methods and compositions for treating age-related macular degeneration | |
TW200806297A (en) | Methods for treating cognitive and other disorders | |
MX2010007543A (es) | Inhibidores de iap. | |
UA96265C2 (ru) | Композиция и способ ингибирования jak пути передачи сигнала | |
WO2009137795A3 (en) | Methods for treating endoplasmic reticulum (er) stress disorders | |
EP2099458A4 (en) | COMPOUNDS AND METHODS FOR IMAGING AND THERAPY OF ENZYME-MEDIATED TUMORS |